Success Metrics

Clinical Success Rate

94.5%

Based on 69 completed trials

Completion Rate

95%(69/73)

Active Trials

1(1%)

Results Posted

43%(30 trials)

Terminated

4(5%)

Phase Distribution

Ph phase_2

12%

Ph not_applicable

34%

Ph phase_1

23%

Ph early_phase_1

Ph phase_3

Ph phase_4

10%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution84 total trials

Early Phase 1First-in-human

8(9.5%)

Phase 1Safety & dosage

20(23.8%)

Phase 2Efficacy & side effects

10(11.9%)

Phase 3Large-scale testing

8(9.5%)

Phase 4Post-market surveillance

9(10.7%)

N/ANon-phased studies

29(34.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

89.6%

69 of 77 finished

Non-Completion Rate

10.4%

8 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(69)

Terminated(8)

Other(7)

Detailed Status

Completed69

Terminated4

unknown4

Withdrawn4

Suspended3

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

94.5%

Most Advanced

Phase 4

Trials by Phase

Early Phase 18 (9.5%)

Phase 120 (23.8%)

Phase 210 (11.9%)

Phase 38 (9.5%)

Phase 49 (10.7%)

N/A29 (34.5%)

Trials by Status

recruiting11%

terminated45%

unknown45%

withdrawn45%

completed6980%

not_yet_recruiting11%

suspended33%

Recent Activity

1 active trials

Showing 5 of 86

completedearly_phase_1

Clinical Trials (86)

Showing 20 of 86 trialsScroll for more

NCT06096714Early Phase 1

Addictive Threshold of Nicotine

Completed

NCT06334016Early Phase 1

Evaluating the Delivery and Effects of THC Vaping Liquids in the Bloodstream

Not Yet Recruiting

NCT03652740Phase 1

Effects of Commonly Used Medications on Mood and Choice

Completed

NCT05999383Phase 2

Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration

Recruiting

NCT03635333Phase 1

Effects of E-Cigarette Flavors on Adults TCORS 2.0

Completed

NCT05278065Not Applicable

E-cigarettes for Harm Reduction in Adults With Asthma

Completed

NCT04231539Not Applicable

Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study

Completed

NCT05335915Phase 1

Acute Pharmacokinetic and Pharmacodynamic Effects of "Tobacco-Free" Oral Nicotine Pouches in Smokers

Completed

NCT03281694Phase 1

The Use of AVL-3288 to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine

Withdrawn

NCT00385216Phase 4

Nicotine as an Adjuvant Analgesic for Third Molar Surgery

Completed

NCT04521647Phase 1

Effects of Menthol in E-cigarettes on Smoking Behaviors

Completed

NCT04535362Early Phase 1

Nicotine's Potential Abuse With Menthol

Completed

NCT03634839Phase 1

Effects of E-cigarette Flavors on Youth TCORS 2.0

Completed

NCT03235505Phase 4

Efficacy and Safety of E-cigarettes for Smoking Cessation in Middle-aged Heavy Smokers

Completed

NCT03091699Phase 3

Effects of Exercise and Nicotine on Cognition in Smokers

Completed

NCT04124432Phase 1

Behavioral Pharmacology of Cannabis and Nicotine

Completed

NCT06259630Phase 4

Nicotine Virtual Reality Conditioned Place Preference

Withdrawn

NCT06027723Early Phase 1

Nicotine and Pavlovian Bias

Unknown

NCT02955329Phase 3

Vaping THC From Electronic Cigarettes

Completed

NCT00002520Not Applicable

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Completed

Drug Details

Intervention Type: DRUG
Total Trials: 86